Attached files

file filename
EX-31.2 - EXHIBIT 31.2 - CHAMPIONS ONCOLOGY, INC.csbrex312.htm
EX-31.1 - EXHIBIT 31.1 - CHAMPIONS ONCOLOGY, INC.csbrex311.htm
EX-23.1 - EXHIBIT 23.1 - CHAMPIONS ONCOLOGY, INC.csbrex231.htm
EX-21 - EXHIBIT 21 - CHAMPIONS ONCOLOGY, INC.csbrex21.htm
10-K - 10-K - CHAMPIONS ONCOLOGY, INC.csbr10-k4302016.htm


EXHIBIT 32.1
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002
 
In connection with the Annual Report of Champions Oncology, Inc. (the “Company”) on Form 10-K for the year ended April 30, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the U.S. Sarbanes-Oxley Act of 2002, that to the best of our knowledge:
 
(i) the Report fully complies with the requirements of section 13(a) or 15(d) of the U.S. Securities Exchange Act of 1934; and
 
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
/s/  Joel Ackerman
 
Joel Ackerman
 
Chief Executive Officer
 
(Principal Executive Officer)
 
 
 
/s/  David Miller
 
David Miller
 
Vice President, Finance
 
(Principal Financial Officer)
 
Date: July 29, 2016